Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2365
    PDF: 1673
    HTML: 303
  • Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

    Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola
    e2026059
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.059
    125
    PDF: 89
    HTML: 8
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3774
    PDF: 1495
    HTML: 190
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1781
    PDF: 866
    HTML: 321
  • Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

    Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
    e2025045
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.045
    1712
    PDF: 1267
    HTML: 359
  • CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

    Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone
    e2024010
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.010
    4424
    PDF: 3636
    HTML: 226
  • Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

    Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani
    e2025027
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.027
    1478
    PDF: 1260
    HTML: 318
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1556
    PDF: 1186
    HTML: 296
  • CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES

    Ugo Testa, Prof. Patrizia Chiusolo, Dr. Elvira Pelosi, Dr. Germana Castelli, Giuseppe Leone
    e2024031
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.031
    2239
    PDF: 2073
    HTML: 202
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2408
    PDF: 1875
    HTML: 154
  • CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL

    Ugo Testa, Dr. Elvira Pelosi, Dr. Germana Castelli, Dr. Alberto Fresa, Prof. Luca Laurenti
    e2024045
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.045
    3755
    PDF: 1642
    HTML: 83
  • SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

    Firas Kreidieh, Sally Temraz
    e2020078
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.078
    1126
    PDF: 973
    HTML: 345
  • Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

    Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello
    e2025043
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.043
    1217
    PDF: 977
    HTML: 160
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    2010
    PDF: 1689
    HTML: 197
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    4467
    PDF: 1538
    HTML: 1564
    Untitled: 243
  • BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL

    Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo
    e2024070
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.070
    1684
    PDF: 1117
    HTML: 131
  • INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

    Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene
    e2018029
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.029
    2921
    PDF: 1085
    HTML: 310
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1688
    PDF: 660
    HTML: 2438
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    999
    PDF: 1231
    HTML: 117
  • CLASSICAL HODGKIN LYMPHOMA TODAY

    Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.055
    487
    PDF: 313
    HTML: 65
  • CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

    Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone
    e2013031
    2013-05-01
    https://doi.org/10.4084/mjhid.2013.031
    3285
    PDF: 916
    HTML: 1548
    Fig.1 CHL-R paper: 228
    Fig 2 CHL-R paper: 252
  • UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

    José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano
    e2024065
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.065
    4096
    Suppl. Files: 1176
    PDF: 1099
    Html: 192
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    1906
    PDF: 1732
    HTML: 909
  • Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure

    SUPARNO CHAKRABARTI
    e2020047
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.047
    1243
    PDF: 937
    HTML: 293
  • OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

    Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst
    e2023025
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.025
    1383
    HTML: 333
    PDF: 968
    Suppl. Files: 477
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    1469
    PDF: 384
    Html: 163
  • NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

    Dimitar Efremov, Adrian Wiestner, Luca Laurenti
    e2012067
    2012-10-09
    https://doi.org/10.4084/mjhid.2012.067
    2585
    PDF: 863
    HTML: 8918
    Efremov 1: 242
    Efremov 2: 207
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    771
    PDF: 596
    HTML: 48
  • Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

    Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti
    e2022043
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.043
    1403
    PDF: 597
    HTML: 228
  • EBV IN HODGKIN LYMPHOMA

    Giuseppina Massini, Doerte Siemer, Stefan Hohaus
    e2009013
    https://doi.org/10.4084/mjhid.2009.013
    1688
    PDF: 614
    HTML: 13962
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    2150
    PDF: 1076
    HTML: 1212
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    1927
    PDF: 793
    HTML: 547
  • EFFICACY AND SAFETY OF THALIDOMIDE IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVALUATION

    Jialian Li, Ping Ji, Qinyue Zhong, Lin Dong, Hai Yi, Baiyu Chen, Xu Zhang, Tingting Duan
    e2026033
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.033
    274
    PDF: 286
    Suppl. Files: 46
    HTML: 41
  • POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

    Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.028
    1099
    PDF: 535
    Suppl. Files: 132
    HTML: 251
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori
    e2012075
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.075
    2629
    PDF: 884
    HTML: 2127
  • Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

    Pier Luigi Zinzani, Ginevra Lolli, Beatrice Casadei, Lisa Argnani, Laura Nanni, Michele Cavo
    e2020040
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.040
    1139
    PDF: 703
    HTML: 206
  • Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

    Daniele Derudas
    e2025025
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.025
    1590
    PDF: 1403
    HTML: 137
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2212
    PDF: 1739
    HTML: 386
  • Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma

    Martina Canichella, Stefano Fratoni, Carla Mazzone, alice di rocco, elisabetta abruzzese
    e2026014
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.014
    893
    PDF: 734
    Html: 145
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

    Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
    e2012069
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.069
    2590
    PDF: 746
    HTML: 1536
1 - 40 of 40 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.